Quintiles shutters a medical education outfit; BioPharma Services opens new Phase I shop;

> Quintiles ($Q) is closing down a medical education operation in New York, according to a local report, cutting 27 jobs in the process. News

> Canada's BioPharma Services has opened a new 48-bed Phase I facility in Columbia, MO. Story

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.